82 Results

People

  1. Levine
    Levine
  2. Stein
    Stein
  3. Giralt
    Giralt
  4. Tallman
    Tallman
  5. Armstrong
    Armstrong
  6. Papadopoulos
    Papadopoulos
  7. Perales
    Perales
  8. Abdel-Wahab
    Abdel-Wahab
  9. Jakubowski
    Jakubowski
  10. Koche
    Koche

Groups

  1. Department of Medicine (59)
  2. Center for Hematologic Malignancies (53)
  3. Hematologic Malignancies, Division of (52)
  4. Adult Leukemia (31)
  5. GSK Faculty (24)
  6. Executive Committee, Center for Hematologic Malignancies (15)
  7. Bone Marrow Transplant (13)
  8. Tow Center for Developmental Oncology (TCDO) (13)
  9. Human Oncology and Pathogenesis Program (12)
  10. Center for Molecular Imaging and Biotechnology (11)
  1. "acute myeloid-leukemia"
Formats
  1. Journal Article (73)
  2. Review (7)
  3. Conference Paper (1)
  4. Guidelines (1)
Groups
  1. Department of Medicine (59)
  2. Center for Hematologic Malignancies (53)
  3. Hematologic Malignancies, Division of (52)
  4. Adult Leukemia (31)
  5. GSK Faculty (24)
  6. Executive Committee, Center for Hematologic Malignancies (15)

More Groups

People
  1. Martin Tallman (11)
  2. Eytan Stein (9)
  3. Ross Levine (9)
  4. Sergio Giralt (6)
  5. Esperanza Papadopoulos (5)
  6. Miguel-Angel Perales (5)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (6)
  6. 2020 (4)

More Years

Publications
  1. Blood (14)
  2. Journal of Clinical Oncology (8)
  3. Leukemia (5)
  4. Blood Advances (4)
  5. Bone Marrow Transplantation (4)
  6. Biology of Blood and Marrow Transplantation (3)

More Publications

Publishers
  1. American Society of Hematology (20)
  2. Nature Publishing Group (16)
  3. American Society of Clinical Oncology (8)
  4. Elsevier Inc. (8)
  5. American Association for Cancer Research (4)
  6. Harborside Press (3)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AML
    Journal Article

    Alhajahjeh, A.; Patel, K. K.; Shallis, R. M.; Podoltsev, N. A.; Kewan, T.; Stempel, J. M.; Mendez, L.; Huntington, S. F.; Stahl, M.; Goshua, G.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: Adapting Pre-MEASURE to clinical practice
    Review

    Shaffer, B. C.; Kebriaei, P.; de Lima, M.; Jimenez, A. M. J.
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • IDH1/2 mutations in cancer: Unifying insights and unlocking therapeutic potential for chondrosarcoma
    Review

    Deshmukh, S.; Kelly, C.; Tinoco, G.
    Targeted Oncology (2025)

    Fulltext@MSK | Save
  • Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML
    Journal Article

    Bewersdorf, J. P.; Shimony, S.; Shallis, R. M.; Liu, Y.; Berton, G.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations
    Journal Article

    Miao, H.; Chen, D.; Ropa, J.; Purohit, T.; Kim, E.; Sulis, M. L.; Ferrando, A.; Cierpicki, T.; Grembecka, J.
    Leukemia (2024)

    Fulltext@MSK | Save
  • Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: A patient-level meta-analysis of 100 000 women from 86 randomised trials
    Journal Article

    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
    Lancet (2023)

    Fulltext@MSK | Save
  • Treating accelerated and blast phase myeloproliferative neoplasms: Progress and challenges
    Review

    Ajufo, H. O.; Waksal, J. A.; Mascarenhas, J. O.; Rampal, R. K.
    Therapeutic Advances in Hematology (2023)

    Fulltext@MSK | Save
  • Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
    Guidelines

    Döhner, H.; Wei, A. H.; Appelbaum, F. R.; Craddock, C.; DiNardo, C. D.; Dombret, H.; Ebert, B. L.; Fenaux, P.; Godley, L. A.; Hasserjian, R. P.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • PU.1-dependent enhancer inhibition separates Tet2-deficient hematopoiesis from malignant transformation
    Journal Article

    Aivalioti, M. M.; Bartholdy, B. A.; Pradhan, K.; Bhagat, T. D.; Zintiridou, A.; Jeong, J. J.; Thiruthuvanathan, V. J.; Pujato, M.; Paranjpe, A.; Zhang, C.; more...
    Blood Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Systematic literature review and meta-analysis on use of thrombopoietic agents for chemotherapy-induced thrombocytopenia
    Review

    Soff, G. A.; Ray-Coquard, I.; Rivera, L. J. M.; Fryzek, J.; Mullins, M.; Bylsma, L. C.; Park, J. K.
    PLoS ONE (2022)

    Fulltext@MSK | Save